We are live on
!
Find out more
FCM
Frontier Capital Management Portfolio holdings
AUM
$10.7B
1-Year Est. Return
67.78%
This Fund
S&P 500
This Quarter
Est. Return
+10.27%
1 Year Est. Return
+67.78%
3 Year Est. Return
+183.84%
5 Year Est. Return
+266.8%
10 Year Est. Return
+1,486.88%
AUM
$12.5B
AUM Growth
+$308M
(+2.5%)
Cap. Flow
-$635M
Cap. Flow
% of AUM
-5.09%
Top 10 Holdings %
Top 10 Hldgs %
13.33%
Holding
360
New
21
Increased
126
Reduced
182
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$83.6M |
| 2 |
SBA Communications
SBAC
|
+$57.8M |
| 3 |
BERY
Berry Global Group, Inc.
BERY
|
+$52.3M |
| 4 |
Willis Towers Watson
WTW
|
+$46.1M |
| 5 |
Woodward
WWD
|
+$43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$127M |
| 2 |
Kirby Corp
KEX
|
+$72.5M |
| 3 |
Analog Devices
ADI
|
+$69.6M |
| 4 |
Fair Isaac
FICO
|
+$51.2M |
| 5 |
WP
Worldpay, Inc.
WP
|
+$47.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.67% |
| 2 | Industrials | 20.78% |
| 3 | Financials | 13.78% |
| 4 | Healthcare | 12.9% |
| 5 | Consumer Discretionary | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CFMS
276
DELISTED
Conformis, Inc. Common Stock
CFMS
| $3.69M | 0.03% |
14,876
+18
| +0.1% | +$3.62K |
|
|
EVHC
277
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.37M | 0.03% |
50,527
-11,877
| -19% | -$818K |
|
278
QuickLogic
QUIK
$187M
| $3.21M | 0.03% |
301,879
-36,441
| -11% | -$455K |
|
|
PAY
279
DELISTED
Verifone Systems Inc
PAY
| $3.03M | 0.02% |
192,663
-5,285
| -3% | -$96K |
|
280
Pacira BioSciences
PCRX
$960M
| $2.87M | 0.02% |
83,748
-18,496
| -18% | -$725K |
|
281
Precigen
PGEN
$2.51B
| $2.71M | 0.02% |
97,581
+5,964
| +7% | +$158K |
|
|
HABT
282
DELISTED
The Habit Restaurants, Inc. - Class A
HABT
| $2.59M | 0.02% |
185,175
-36,400
| -16% | -$560K |
|
|
SGMO
283
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.38M | 0.02% |
514,076
+146
| +0% | +$743 |
|
284
Broadcom
AVGO
$1.62T
| $1.89M | 0.02% |
109,520
-16,260
| -13% | -$272K |
|
|
ITCI
285
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.62M | 0.01% |
106,581
+24,582
| +30% | +$994K |
|
|
MDCO
286
DELISTED
Medicines Co
MDCO
| $1.56M | 0.01% |
41,419
-9,110
| -18% | -$343K |
|
287
UnitedHealth
UNH
$337B
| $1.47M | 0.01% |
10,488
-1,557
| -13% | -$218K |
|
288
Alphabet (Google) Class C
GOOG
$4.18T
| $1.41M | 0.01% |
36,260
-5,400
| -13% | -$205K |
|
|
289
Analog Devices
ADI
$175B
| $1.08M | 0.01% |
16,724
-1,121,979
| -99% | -$69.6M |
|
290
TJX Companies
TJX
$137B
| $1.07M | 0.01% |
28,558
-4,242
| -13% | -$166K |
|
291
Blackrock
BLK
$164B
| $1.03M | 0.01% |
2,851
-423
| -13% | -$154K |
|
292
Cognizant
CTSH
$28.5B
| $988K | 0.01% |
20,702
-3,075
| -13% | -$175K |
|
293
Biogen
BIIB
$31.9B
| $939K | 0.01% |
3,000
-446
| -13% | -$132K |
|
294
Novavax
NVAX
$1.52B
| $892K | 0.01% |
+21,450
| New | +$2.77M |
|
295
American International
AIG
$39.7B
| $875K | 0.01% |
14,742
-2,190
| -13% | -$125K |
|
|
AGN
296
DELISTED
Allergan plc
AGN
| $861K | 0.01% |
3,737
-555
| -13% | -$136K |
|
297
JPMorgan Chase
JPM
$937B
| $836K | 0.01% |
12,560
-1,866
| -13% | -$122K |
|
298
Bristol-Myers Squibb
BMY
$130B
| $817K | 0.01% |
15,151
-2,251
| -13% | -$145K |
|
299
Oracle
ORCL
$404B
| $779K | 0.01% |
19,829
-2,945
| -13% | -$120K |
|
300
Apple
AAPL
$4.84T
| $715K | 0.01% |
25,300
-22,756
| -47% | -$602K |
|
Similar funds
VAS
SIM
FMI
HL
RCMF
DPIM
CA
SCM
Frontier Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Frontier Capital Management held 360 positions worth $12.5B, up 2.5% from $12.2B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Frontier Capital Management withdrew a net $635M in Q3 2016, closing 16 positions and reducing 182 holdings. Its most notable exit was MEDIVATION, INC., an estimated $127M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Industrials and Financials.
Against the trend, Frontier Capital Management opened a new position in Zoetis worth $85.9M.
- Frontier Capital Management's largest Q3 2016 buy was Zoetis: 1,651,328 shares worth $85.9M.
- Frontier Capital Management added most to Berry Global Group, Inc. in Q3 2016, an estimated $52.3M increase.
- Frontier Capital Management's biggest Q3 2016 reduction was Kirby Corp, cutting an estimated $72.5M.
- Frontier Capital Management fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $127M.
- Frontier Capital Management's ten largest holdings make up 13% of its $12.5B portfolio in Q3 2016.
- Frontier Capital Management opened 21 new positions and closed 16 in Q3 2016.
- Frontier Capital Management's portfolio value rose 2.5% quarter-over-quarter to $12.5B.
Based on Frontier Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.